ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
X-Chem, a provider of DNA-encoded libraries for drug discovery, has been bought by the European investment firm GHO Capital Partners for an undisclosed sum from two other investment firms. Based in Waltham, Massachusetts, X-Chem provides libraries containing over 200 billion small molecules. It counts Bayer, Pfizer, and Roche among its partners. Founder and current senior vice president of chemistry Matt Clark has become CEO.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter